Lyceum Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.00 Cr
as on 23-10-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.96 Cr
as on 23-10-2024
- Revenue 112.28%
(FY 2023)
- Profit 118.44%
(FY 2023)
- Ebitda 119.55%
(FY 2023)
- Net Worth 85.98%
(FY 2023)
- Total Assets 97.10%
(FY 2023)
About Lyceum Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹5.96 Cr.
Laltu Adhikari, Mrinal Ghosh, and Sanjay Maitra serve as directors at the Company.
- CIN/LLPIN
U24304GJ2019PTC108793
- Company No.
108793
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lyceum Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laltu Adhikari  | Director | 21-Jun-2019 | Current |
| Mrinal Ghosh | Director | 16-Oct-2019 | Current |
| Sanjay Maitra | Whole-Time Director | 21-Sep-2020 | Current |
Financial Performance of Lyceum Life Sciences.
Lyceum Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 112.28% increase. The company also saw a substantial improvement in profitability, with a 118.44% increase in profit. The company's net worth Soared by an impressive increase of 85.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lyceum Life Sciences?
In 2023, Lyceum Life Sciences had a promoter holding of 7.00% and a public holding of 93.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lyceum Lifestyle Private LimitedActive 1 year 4 monthsMrinal Ghosh and Sanjay Maitra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 17 Jun 2023 | ₹2.05 M | Open |
Others Creation Date: 16 Jun 2023 | ₹7.00 M | Open |
Hdfc Bank Limited Creation Date: 10 Oct 2022 | ₹5.00 Cr | Open |
How Many Employees Work at Lyceum Life Sciences?
Lyceum Life Sciences has a workforce of 166 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lyceum Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lyceum Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
